SELLAS Life Sciences Group, Inc. (SLS) Misses Q1 EPS by 18c
Get Alerts SLS Hot Sheet
Join SI Premium – FREE
SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) reported Q1 EPS of ($0.47), $0.18 worse than the analyst estimate of ($0.29).
For earnings history and earnings-related data on SELLAS Life Sciences Group, Inc. (SLS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- Braze stock tumbles 10% on weak third quarter EPS guidance
- HSBC Raises S&P500 Target to 8,100
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share